Stockreport

Baudax Bio +7% premarket on Anjeso launch in U.S. [Seeking Alpha]

Baudax Bio, Inc.  (BXRX) 
PDF Baudax Bio (NASDAQ:BXRXannouncesANJESO is indicated for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics.Full commercia [Read more]